Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Parsons

Showing results (71-80 of 641) with videos related to

Pageof 65
Sort By:
The Lancet. Oncology|February 7, 2019
Pharmacologic management of cognitive impairment induced by cancer therapyPhilipp Karschnia, Michael W Parsons, Jorg Dietrich
Cancer Research|April 24, 2024
Exploring Novel Therapeutic Avenues for Chemotherapy-Related Cognitive ImpairmentJorg Dietrich, Michael W Parsons, Emiliano Santarnecchi
The Lancet. Neurology|October 21, 2022
Tenecteplase versus alteplase for early treatment of ischaemic stroke - Authors' replyLeonid Churilov, Andrew Bivard, Mark W Parsons
International Journal of Stroke : Official Journal of the International Stroke Society|January 20, 2015
Repeat brain imaging after thrombolysis is importantBruce C V Campbell, Mark W Parsons
The Journal of Gene Medicine|August 19, 2014
Long-term therapeutic and reporter gene expression in lentiviral vector treated cystic fibrosis micePatricia Cmielewski, Martin Donnelley, David W Parsons
Radiology|February 1, 1994
Assessing adequacy of mammographic image qualityG W Eklund, G Cardenosa, W Parsons
Journal of Stroke|January 8, 2014
Perfusion patterns of ischemic stroke on computed tomography perfusionLongting Lin, Andrew Bivard, Mark W Parsons
The Medical Journal of Australia|May 25, 2012
Sudden limb weaknessBill O'Brien, Mark W Parsons, Craig S Anderson
Journal of Allied Health|September 16, 2009
Interprofessional, practice-driven research: reflections of one "community of inquiry" based in acute strokeI J Hubbard, G Vyslysel, M W Parsons
Respiratory Research|June 24, 2010
Lysophosphatidylcholine as an adjuvant for lentiviral vector mediated gene transfer to airway epithelium: effect of acyl chain lengthPatricia Cmielewski, Don S Anson, David W Parsons
Pageof 65

Showing results (71-80 of 641) with videos related to

Sort By:
Pageof 65
The Lancet. Oncology|February 7, 2019
Pharmacologic management of cognitive impairment induced by cancer therapyPhilipp Karschnia, Michael W Parsons, Jorg Dietrich
Cancer Research|April 24, 2024
Exploring Novel Therapeutic Avenues for Chemotherapy-Related Cognitive ImpairmentJorg Dietrich, Michael W Parsons, Emiliano Santarnecchi
The Lancet. Neurology|October 21, 2022
Tenecteplase versus alteplase for early treatment of ischaemic stroke - Authors' replyLeonid Churilov, Andrew Bivard, Mark W Parsons
International Journal of Stroke : Official Journal of the International Stroke Society|January 20, 2015
Repeat brain imaging after thrombolysis is importantBruce C V Campbell, Mark W Parsons
The Journal of Gene Medicine|August 19, 2014
Long-term therapeutic and reporter gene expression in lentiviral vector treated cystic fibrosis micePatricia Cmielewski, Martin Donnelley, David W Parsons
Radiology|February 1, 1994
Assessing adequacy of mammographic image qualityG W Eklund, G Cardenosa, W Parsons
Journal of Stroke|January 8, 2014
Perfusion patterns of ischemic stroke on computed tomography perfusionLongting Lin, Andrew Bivard, Mark W Parsons
The Medical Journal of Australia|May 25, 2012
Sudden limb weaknessBill O'Brien, Mark W Parsons, Craig S Anderson
Journal of Allied Health|September 16, 2009
Interprofessional, practice-driven research: reflections of one "community of inquiry" based in acute strokeI J Hubbard, G Vyslysel, M W Parsons
Respiratory Research|June 24, 2010
Lysophosphatidylcholine as an adjuvant for lentiviral vector mediated gene transfer to airway epithelium: effect of acyl chain lengthPatricia Cmielewski, Don S Anson, David W Parsons
Pageof 65